These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7564996)

  • 41. [Survey of leprosy disabilities in patients treated with multiple drug therapy in Ivory Coast].
    Tiendrebéogo A; Djakeaux DS; Assé H; Eba ME; Sica A
    Acta Leprol; 1997; 10(3):151-8. PubMed ID: 9281294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
    Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
    Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advances in the treatment of leprosy.
    Ishii N
    Dermatol Online J; 2003 Mar; 9(2):5. PubMed ID: 12639458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leprosy and HIV co-infection in five patients.
    Trindade MA; Manini MI; Masetti JH; Leite MA; Takahashi MD; Naafs B
    Lepr Rev; 2005 Jun; 76(2):162-6. PubMed ID: 16038250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relapse rates following leprosy multidrug therapy.
    Suite M
    West Indian Med J; 2000 Sep; 49(3):210-1. PubMed ID: 11076211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
    Jain M; Singh N; Bhatia A; Arora VK
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are 18 doses of WHO/MDT sufficient for multibacillary leprosy; results of a trial in Malawi.
    Pönnighaus JM; Boerrigter G
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):1-7. PubMed ID: 7730703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials.
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis of leprosy.
    Krishnamurthy P
    J Indian Med Assoc; 2006 Dec; 104(12):680-1, 685. PubMed ID: 17474284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delay in presentation, an indicator for nerve function status at registration and for treatment outcome--the experience of the Bangladesh Acute Nerve Damage Study cohort.
    Nicholls PG; Croft RP; Richardus JH; Withington SG; Smith WC
    Lepr Rev; 2003 Dec; 74(4):349-56. PubMed ID: 14750580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leprosy today.
    Noordeen SK
    Schweiz Med Wochenschr; 1993 Jun; 123(24):1228-36. PubMed ID: 8327871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of results of surgical decompression of median nerve in leprosy in relation to sensory--motor functions.
    Husain S; Mishra B; Prakash V; Malaviya GN
    Acta Leprol; 1997; 10(4):199-201. PubMed ID: 9447252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):311-8. PubMed ID: 14750576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hot topics in leprosy.
    Handa S; Dogra S
    Lepr Rev; 2003 Mar; 74(1):87-8. PubMed ID: 12669939
    [No Abstract]   [Full Text] [Related]  

  • 58. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bigger may not always be better: giant borderline tuberculoid leprosy lesion.
    Ghorpade A
    Lepr Rev; 2005 Jun; 76(2):182-3. PubMed ID: 16038255
    [No Abstract]   [Full Text] [Related]  

  • 60. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.